Financial Performance - The company's operating revenue for Q1 2023 was ¥102,012,228.80, a decrease of 39.93% compared to ¥169,816,482.06 in the same period last year[5] - Net profit attributable to shareholders was ¥9,540,054.26, down 56.66% from ¥22,013,796.32 year-on-year[5] - The total profit for Q1 2023 was ¥10,556,882.14, down 57.89% from ¥25,067,759.65 in Q1 2022[8] - Basic earnings per share fell by 67.48% to ¥0.1193 from ¥0.3669 in the previous year[5] - Total operating revenue for Q1 2023 was ¥102,012,228.80, a decrease of 40% compared to ¥169,816,482.06 in the same period last year[16] - Net profit for Q1 2023 was ¥9,540,054.26, a decline of 56.7% from ¥22,013,796.32 in Q1 2022[18] - Earnings per share for Q1 2023 were ¥0.1193, compared to ¥0.3669 in the same period last year, reflecting a decrease of 67.5%[19] Cash Flow - The net cash flow from operating activities decreased by 21.09% to ¥19,397,759.48 from ¥24,582,429.12 in Q1 2022[5] - Cash inflow from operating activities was ¥64,209,911.03, down 38.8% from ¥105,021,420.64 in Q1 2022[21] - The total cash outflow from operating activities was CNY 44,812,151.55, compared to CNY 80,438,991.52 in the same period last year, indicating a reduction of about 44.4%[22] - The net cash flow from investment activities improved significantly to ¥19,709,745.70 from a negative ¥10,261,448.66 in the same period last year[9] - Cash inflow from investing activities totaled CNY 20,078,795.70, while cash outflow was CNY 369,050.00, resulting in a net positive cash flow[22] - The net increase in cash and cash equivalents for the quarter was CNY 38,863,475.04, compared to CNY 14,329,324.59 in Q1 2022, reflecting an increase of approximately 171.5%[22] - The ending balance of cash and cash equivalents was CNY 366,696,430.78, up from CNY 43,473,379.23 at the end of Q1 2022[22] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥768,011,215.32, a decrease of 2.04% from ¥784,022,630.65 at the end of the previous year[5] - The company's total current assets as of March 31, 2023, are 652,942,256.85 CNY, a decrease from 665,235,906.33 CNY at the beginning of the year[14] - The total liabilities for the company are 86,553,652.43 CNY, reduced from 112,236,051.89 CNY[14] - The company's total liabilities decreased to ¥90,034,437.50 from ¥115,852,467.03, a reduction of 22.3%[18] - Total equity attributable to shareholders increased to ¥677,976,777.82 from ¥668,170,163.62, an increase of 1.2%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,846[10] - The largest shareholder, Longkou Sunshine Chemical Co., Ltd., holds 42.83% of shares, totaling 34,260,000 shares[10] - The second-largest shareholder, Li Xiumei, owns 19.43% of shares, amounting to 15,540,000 shares[10] - The top ten shareholders include both natural persons and corporate entities, with significant ownership concentration[10] Other Financial Metrics - The weighted average return on equity decreased to 1.42% from 6.18% in the previous year[5] - Research and development expenses for Q1 2023 were ¥4,221,623.72, down 19.1% from ¥5,214,460.67 in Q1 2022[16] - The company reported a financial expense of -¥720,134.29, compared to a financial income of ¥221,592.71 in the previous year[18] - The company has no preferred shareholders as of the reporting period[12] - The company did not undergo an audit for the Q1 2023 report[23]
联合化学(301209) - 2023 Q1 - 季度财报